Mechanical Components

Japan opens a pre-review path for home-use rehab exoskeletons, signaling reimbursement progress from October 2026. See what it means for distributors, OEMs, and certified rehab robot suppliers.

Japan opens reimbursement pre-screening for rehab exoskeletons, boosting access for ISO 13482:2023 Class B lower-limb devices in home and outpatient care. See who benefits first.

APREHAB 2026 opens exoskeleton reimbursement pre-screening in Tokyo, linking rehab robot procurement with JP medical insurance access. See what manufacturers and buyers should prepare now.

Robotic rehabilitation systems for stroke work best when matched to each recovery stage. Explore how to compare safety, workflow, and therapy value before choosing a system.

APREHAB 2026 spotlights exoskeleton rehab robots with a new dedicated zone and Japan access track, helping manufacturers, buyers, and regulatory teams explore procurement, PMDA review readiness, and faster market-entry planning.

Medical exoskeletons CE certified: compare safety, patient fit, data integration, and lifetime service costs before procurement to choose a rehab system that delivers lasting value.

Medical exoskeletons powered systems compared: discover key differences in motors, batteries, and gait support to evaluate safer rehab performance, smarter procurement, and better clinical outcomes.

Medical robotics North America is reshaping care delivery. Explore key applications, adoption barriers, and the buyers driving growth across surgery, rehab, and infection control.

Exoskeleton rehab robot lead times extend to 26 weeks as actuator IC shortages and reducer constraints tighten supply. See what this means for sourcing, orders, and delivery planning.